ArticleJournal of clinical laboratory analysis2022

Nucleocapsid protein of SARS-CoV-2 is a potential target for developing new generation of vaccine.

Weixu Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.